Text Size

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Indiana University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00572780
First received: December 11, 2007
Last updated: NA
Last verified: December 2007
History: No changes posted
  Purpose

Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.


Condition
Crohn's Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease

Resource links provided by NLM:

MedlinePlus related topics: Crohn's Disease
U.S. FDA Resources

Further study details as provided by Indiana University:

Estimated Enrollment: 2000
Study Start Date: August 2007
Estimated Study Completion Date: August 2009
Groups/Cohorts
CTE with CD
Crohn's disease patients who underwent a CT enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Crohn's disease patients that have had a CT Enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease will be eligible. Subjects who were later diagnosied with bowel malignancy and subjects with a period of follow-up of less than 1 year(without surgery) will be excluded.

Criteria

Inclusion Criteria:

  • Crohn's disease with CT Enteroclysis during symptomatic treatment

Exclusion Criteria:

  • Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
  • Crohn's disease subjects that were later diagnosed with a bowel malignancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00572780

Locations
United States, Indiana
Indiana University
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Investigators
Principal Investigator: Michael V. Chiorean, M.D. Indiana University
  More Information

No publications provided

Responsible Party: Michael V. Chiorean M.D., Indiana University
ClinicalTrials.gov Identifier: NCT00572780     History of Changes
Other Study ID Numbers: 070759
Study First Received: December 11, 2007
Last Updated: December 11, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Indiana University:
Crohn's Disease
CT Enteroclysis

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastroenteritis
 Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases

ClinicalTrials.gov processed this record on June 18, 2013